Price T Rowe Associates Inc Enveric Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.8 - $16.2 $946,000 - $1.74 Million	-107,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.5 - $52.0 $392,500 - $1.63 Million	-31,400 Reduced 22.61%	107,500 $35,000
Q4 2021 Feb 14, 2022	BUY	$46.5 - $104.0 $3.99 Million - $8.92 Million	85,800 Added 161.58%	138,900 $129,000
Q3 2021 Nov 15, 2021	BUY	$80.5 - $175.0 $4.27 Million - $9.29 Million	53,100 New	53,100 $110,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.